Get started
CDW Bullish Setup – 1:27 R:R at Strong Support with Doji CandleNASDAQ:CDW has arrived at a strong support level, aligning with a historical bullish trendline, making this a key area to watch. The all-time high (ATH) is not far off, offering a great upside potential if the stock rebounds from here. A doji candle has now formed at support, signaling indecision and a possible reversal. With a 1:27 risk-to-reward ratio until ATH, this setup presents an attractive buying opportunity if momentum picks up. Watching for confirmation of a bounce! 📈🚀
NASDAQ:CDWLong
by PattRec
Opening (IRA): TTD May 16th -70C/October 17th 32.5C LCD*... for a 26.10 debit. Comments: At or near 52-week lows. Buying the back month 90 delta and selling the front month that pays for all of the extrinsic in the long. (The October 17th 32.5C is shown at the 50 strike to fit it on the chart). Metrics: Buying Power Effect: 26.10 debit Break Even: 58.60/share Max Profit: 11.40 ROC at Max: 43.7% 10% Max: 2.61 ROC at 10% Max: 10.0% In this particular case, I'll look to take profit at 110% of what I put it on for and/or roll out the short call if it hits 50% max. Earnings are on 5/14, so my preference would be to take it off before then ... . * -- Long Call Diagonal.
NASDAQ:TTDLong
by NaughtyPines
$DE Breaking Out of Flat Base?I went long NYSE:DE on Mar 5th after it bounced right back over the 50 DMA (red). It had been choppy, so I waited to add to the position until today. Why today? If you look you can see the pattern of the candles kept getting tighter and consolidating around the shorter term EMAs. I had drawn in what felt to me to be a resemblance of a flat base pattern. It broke above that with conviction this morning, so I have added to bring up to a full-size position. My stop on the added portion will be just below the LOD and the remaining stop has been moved up to the most recent higher low. If you like this idea, please make sure it fits with your trading plan. These are simply my ideas.
NYSE:DELong
by jaxdog
Why Going Long on SoFi Stock SoFi Technologies (SOFI) is at a pivotal moment, presenting a strong long opportunity as it enters the 5th wave of an Elliott Wave cycle. This final leg typically brings explosive upside momentum, signaling a potential breakout. While a brief dip below $10 is possible, this could act as a springboard for a powerful rally toward $20 and beyond. The stock's bullish structure, combined with SoFi's growing financial services business, makes it an attractive bet for long-term investors. With momentum building, now may be the perfect time to go long on SoFi before the next surge begins. 🚨 This is not financial advice. Do your own due diligence (DD) before making any investment decisions. 🚨
NASDAQ:SOFILong
by SabahEquityResearch
1
Opening (IRA): TGT April 17th -108C/October 17th 75C LCD*... for a 30.05 debit. Comments: At or near a 52-week low. Buying the back month 90 delta and selling the front month strike that pays for all of the extrinsic in the long. (The 75C is shown at the 100 strike so that it fits on the chart). Metrics: Buying Power Effect: 30.05 Break Even: 105.05 Max Profit: 2.95 ROC at Max: 9.82% 50% Max: 1.48 ROC at 50% Max: 4.91% Will generally look to take profit at 50% max and/or roll the short call at 50% max to lower my downside break even. * -- Long Call Diagonal.
NYSE:TGTLong
by NaughtyPines
NVDA at a decision point, same area as September 2024Price as of my analysis: $113.76 NVDA is sitting at a major horizontal support zone around $113.50. This level acted as strong support in June 2024 and again in September 2024, where it launched a 34% rally toward the $152 range. Price is now testing that same level again — this is a key decision point. If this support breaks, my first downside target is $104.70, followed by $100.96. The $100 level is also psychological support and could attract buyers if tested. At the same time, NVDA is also pressing against a downtrend line that began in mid-February 2025, starting from the ~$143 level. Price rejected off this trendline again on Monday, confirming sellers are defending it. The 10 EMA and 20 EMA on the daily chart sit around $119. For any upside to unfold, NVDA must reclaim these levels. Above that, we’re looking at resistance between $125–130, which is a confluence zone: Downward-sloping 50 SMA Flat 200 SMA The prior uptrend line from May 2023, now acting as potential resistance If the bounce begins here at $113.50, reclaiming the EMAs would be the first bullish signal. Clearing the $125–130 area could open the path back to $141, which was the breakdown candle from February. On the weekly chart, the same $113.50 level shows as significant. The weekly EMAs are starting to turn down, and this week’s candle is showing signs of indecision — suggesting a potential reversal or further breakdown is brewing. Watching how this week closes will be key. Summary: Holding $113.50 = potential bounce toward $119 → $125–130 → $141 Losing $113.50 = likely flush to $104.70 → $100.96 $100 = psychological support and probable strong demand zone Currently at the intersection of major support and downtrend resistance = high-stakes decision zone
NASDAQ:NVDA
by emanuelaelias
Breaking: Alvotech Shares Dips 5% On Earnings Report Shares of Alvotech (NASDAQ: NASDAQ:ALVO ) saw a noteworthy downtick of 5% amidst earnings report yesterday after market close. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. Financial Performance In 2024, Alvotech's revenue was $491.98 million, an increase of 426.84% compared to the previous year's $93.38 million. Losses were -$231.86 million, -57.98% less than in 2023. Highlights of the Financial Results for 2024 Full Year Cash position and sources of liquidity: As of December 31, 2024, the Company had cash and cash equivalents of $51.4 million. Product Revenue: Product revenue was $273.5 million for the year ended December 31, 2024, compared to $48.7 million for the same period in the prior year. License and Other Revenue: License and other revenue was $216.2 million for the year ended December 31, 2024, compared to $42.7 million for the same period in the prior year. The license and other revenue of $216.2 million was primarily attributable to the achievement of key research and development milestones during 2024: Cost of product revenue: Cost of product revenue was $185.3 million for the year ended December 31, 2024, compared to $160.9 million for the same period in the prior year. Research and development (R&D) expenses: R&D expenses were $171.3 million for the year ended December 31, 2024, compared to $210.8 million for the same period in the prior year. General and administrative (G&A) expenses: G&A expenses were $65.7 million for the year ended December 31, 2024, compared to $76.6 million for the same period in the prior year. Operating profit: Operating profit was $69.6 million for the year ended December 31, 2024, compared to ($354.9) million for the same period in the prior year. Share of net loss of joint venture and loss on sale of interest in joint venture: In June 2024, the Company sold its share in the joint venture for gross proceeds of $18.0 million (less $1.3 million in transaction costs). The sale resulted in a net loss of $3.0 million during the year ended December 31, 2024. Finance income: Finance income was $80.1 million for the year ended December 31, 2024, compared to $4.8 million for the same period in the prior year. Finance costs: Finance costs were $303.2 million for the year ended December 31, 2024, compared to $267.2 million for the same period in the prior year. Loss on extinguishment of financial liabilities: On June 7, 2024, the Company entered into a $965.0 million Senior Loan Facility, maturing in July 2029 that was funded in July 2024. Upon the closing of the Senior Loan Facility, the Company was required to settle its existing debt obligations. Income tax (expense) / benefit: Income tax expense was $14.3 million for the year ended December 31, 2024, compared to a benefit of $99.3 million for the same period in the prior year. Loss for the Year: Reported net loss was $231.9 million, or ($0.87) per share on a basic and diluted basis, for the year ended December 31, 2024, compared to a reported net loss of $551.8 million, or ($2.42) per share on a basic and diluted basis, for the same period in the prior year.
NASDAQ:ALVO
by DEXWireNews
PALANTIR Correction is over. Targeting $200 end of year.Last time we viewed Palantir Technologies (PLTR) was 1.5 month ago (February 04, see chart below), setting a $110 Target and then calling to wait for a correction: The price action didn't disappoint us and after hitting $110 it gave us the desired pull-back that extended as low as the 1D MA100 (green trend-line). Within the 2-year Channel Up, the 1D MA100 has always been a low risk level to buy. Until however it breaks above its Triangle, a pattern that has been present as an accumulation phase inside the Channel Up on 4 prior occasions, it is possible to see the stock trading sideways towards the 1D MA200 (orange trend-line), not necessarily making a new Low. Regardless of some more sideways price action or instant break-out above the Triangle, the current level remains an excellent long-term buy opportunity. We are targeting $200, which would almost be a +183% rise, a usual growth rally for the stock within its Channel Up. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:PLTRLong
by TradingShot
7